Immunotherapy: Moving beyond PD1 and PDL1 inhibitors

Описание к видео Immunotherapy: Moving beyond PD1 and PDL1 inhibitors

Earn CME for related activities: https://www.naccme.com/oln

In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Vassiliki A. Papadimitrakopoulou discusses immunotherapy in lung cancer beyond PDF1 and PDL1 inhibitors.

© 2017 Imedex, LLC.

Комментарии

Информация по комментариям в разработке